ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, L.
Right arrow Articles by Milman, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, L.
Right arrow Articles by Milman, N
Eur Respir J 1996; 9: 1826-1830
Copyright © ERS Journals Ltd 1996

Original Articles

Prognostic significance of thrombocytosis in patients with primary lung cancer

LM Pedersen and N Milman

In patients with malignancies, thrombocytosis has previously been related to disease stage, histological type, and survival. In the present study, the prevalence of thrombocytosis and the prognostic information provided by platelet counts were analysed in a large cohort of patients with primary lung cancer. At the time of diagnosis, pretreatment platelet counts were retrospectively recorded in 1,115 consecutive patients with histologically proven primary lung cancer. All patients were reviewed regarding histological type, tumour, node, metastasis (TNM) classification stage and survival. The prevalence of thrombocytosis in patients with lung cancer was compared with that in a series of 550 consecutive out-patients with benign lung disorders. In 269 surgically resected patients, postoperative platelet counts were recorded 1-3 months after resection of the tumour. In the follow-up period, thromboembolic episodes diagnosed either clinically or at autopsy were recorded. The overall prevalence of thrombocytosis (> 400 x 10(9) platelets.L-1) in the patients with lung cancer was 32%. The frequency of thrombocytosis was significantly higher compared with the control subjects (32 vs 6%; p < 0.0001). Platelet counts differed significantly among subgroups defined by the TNM classification, with the proportion of patients with > 400 x 10(9) platelets.L-1 greatest in the more advanced TNM stages (stage I and II 23% vs stage III and IV 37%; p < 0.0001). Patients with thrombocytosis had a significantly poorer survival than patients with normal platelet counts (p < 0.0001). In a multivariate survival analysis (Cox model), thrombocytosis continued to correlate strongly with poor survival even when adjusted for histological type, sex, age, and TNM stage (p < 0.001). In surgically resected patients, the frequency of preoperative and postoperative thrombocytosis differed significantly (23.0 vs 8.9%; p < 0.0001). Survival rate was significantly reduced in patients with preoperative thrombocytosis (p = 0.005). Thrombocytosis was not associated with an increased incidence of thromboembolism. In conclusion, thrombocytosis is an independent prognostic factor of survival in patients with primary lung cancer. We suggest that platelet counts should be included in future multivariate analyses of survival in patients with lung cancer.


This article has been cited by other articles:


Home page
 ICVTSHome page
M. Tomita, T. Shimizu, M. Hara, T. Ayabe, and T. Onitsuka
Prognostic impact of thrombocytosis in resectable non-small cell lung cancer
Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 613 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
M. A. Brockmann, A. Giese, K. Mueller, F. j. Kaba, F. Lohr, C. Weiss, S. Gottschalk, I. Nolte, J. Leppert, J. Tuettenberg, et al.
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma
Neuro-oncol, July 1, 2007; 9(3): 335 - 342.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Prevost, L. Boucher, P. Larivee, R. Boileau, and F. Benard
Bone Marrow Hypermetabolism on 18F-FDG PET as a Survival Prognostic Factor in Non-Small Cell Lung Cancer
J. Nucl. Med., April 1, 2006; 47(4): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. M. W. Verheul and H. M. Pinedo
The Importance of Platelet Counts and Their Contents in Cancer
Clin. Cancer Res., August 1, 2003; 9(9): 3219 - 3221.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Trikha, Z. Zhou, J. Timar, E. Raso, M. Kennel, E. Emmell, and M. T. Nakada
Multiple Roles for Platelet GPIIb/IIIa and {alpha}v{beta}3 Integrins in Tumor Growth, Angiogenesis, and Metastasis
Cancer Res., May 1, 2002; 62(10): 2824 - 2833.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Ikeda, H. Furukawa, H. Imamura, J. Shimizu, H. Ishida, S. Masutani, M. Tatsuta, and T. Satomi
Poor Prognosis Associated With Thrombocytosis in Patients With Gastric Cancer
Ann. Surg. Oncol., April 1, 2002; 9(3): 287 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Ferrigno, G. Buccheri, and I. Ricca
Prognostic significance of blood coagulation tests in lung cancer
Eur. Respir. J., April 1, 2001; 17(4): 667 - 673.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. M. W. Verheul, A. S. Jorna, K. Hoekman, H. J. Broxterman, M. F. B. G. Gebbink, and H. M. Pinedo
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets
Blood, December 15, 2000; 96(13): 4216 - 4221.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.